文献速递免疫规划

热稳定性减毒活轮状病毒疫苗(ROTASIIL®)的稳定性

Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®).
PubMed 文献 · Vaccine · 2017-04-20

全球现有疫苗需在2-8°C或-20°C以下连续冷链储运,超温影响效力并导致废弃。轮状病毒病负担主要见于发展中国家和低收入国家,这些国家冷链能力有限。SIIPL开发的热稳定轮状病毒疫苗ROTASIIL®可在25°C以下储存36个月,绕过标准2-8°C冷库,并能在37°C和40°C下耐受18个月及短期55°C暴露,还能耐受从-20°C到42°C的温度冲击。该疫苗含G1、G2、G3、G4和G9血清型,近期在印度获批。

要点

  • ROTASIIL®可在25°C以下储存36个月,完全绕过标准2-8°C冷库。
  • 该疫苗能在37°C和40°C下耐受18个月,并可短期暴露于55°C。
  • 疫苗可耐受从-20°C到42°C的温度冲击,含G1、G2、G3、G4和G9血清型。

核心结论

  • ROTASIIL®热稳定轮状病毒疫苗可在25°C以下储存36个月,并能在37°C和40°C下耐受18个月及短期55°C暴露,有助于缓解冷链相关问题。

研究设计与样本

  • 本文为SIIPL公司对其开发的热稳定减毒活轮状病毒疫苗ROTASIIL®的稳定性描述,未报告研究设计与样本量。

主要发现

  • ROTASIIL®可在25°C以下储存36个月,完全绕过标准2-8°C冷库。
  • 该疫苗能在37°C和40°C下耐受18个月,并可短期暴露于55°C。
  • 疫苗可耐受从-20°C到42°C的温度冲击。
  • 疫苗含G1、G2、G3、G4和G9血清型(UK-Bovine重配株,购自美国国立卫生研究院)。
  • 该疫苗近期在印度获批。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccines currently available across the globe are stored and transported in a continuous cold-chain at 2-8°C or below -20°C. A temperature excursion outside this range affects the potency of the vaccines. Such vaccines need to be discarded leading wastage. The Rotavirus disease burden is predominantly reported in developing and low-income countries and therefore, has entered or poised to enter their national immunization programs. These countries already have several limitations for effective storage, maintenance and distribution of vaccines in a cold-chain and this introduction is expected to further stress this fragile ecosystem. To help mitigate the cold chain related issues, SIIPL has developed a thermostable rotavirus vaccine ROTASIIL® which can be stored at a temperature below 25°C for 36months, completely by-passing the standard 2-8°C cold storages. In addition it has the capability to withstand temperatures of 37°C and 40°C for 18months and short term exposure to 55°C. It can also tolerate a temperature shock of being thawed from an extreme cold temperature of -20°C to a high temperature of 42°C. The vaccine contains serotypes G1, G2, G3, G4 and G9 (UK-Bovine reassortant strains procured from National Institute of Health-USA). The vaccine is recently licensed in India.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Naik SP, Zade JK, Sabale RN, et al. Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®). Vaccine. 2017. PMID: 28434688. doi:10.1016/j.vaccine.2017.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。